Category Development

WHO Drafting Group Agrees Resolution On Health R&D

A closed-door drafting group this evening arrived seemingly easily at agreement on a resolution on broadening work on new ways to fund research and development into medical products, according to participants. The agreement includes the creation of a new expert committee on health R&D, and asks for a WHO proposal on a pooled fund, they said. [Update: draft text now available]

WHO Reforms Health Emergency Response But Who Will Pay The Bill?

Two years after Ebola, the World Health Organization continues to push forward with a thorough overhaul of how it responds to health emergencies. These include Public Health Emergencies of International Concern (PHEICs), such as the Ebola and Zika outbreaks, as well as natural diseases, conflicts, refugee crises, and the like.

WHO Director Advocates Strong Health Systems, Warns Against Profit-Oriented Mechanisms

The World Health Assembly opened today with World Health Organization Director General Margaret Chan repeating that this year has a record number of agenda items and over 3,000 participants. She slapped at profit-seeking mechanisms leading to "slow-motion disasters," which put economic interests above concerns about well-being. In particular, she underlined the lack of research and development for antimicrobial treatments and the rise of chronic non-communicable diseases.

WIPO Copyright Committee In Freewheel Mode; Conversation Continues

It is difficult to understand whether the prospect of a treaty protecting rights of broadcasters is getting nearer or farther away at the World Intellectual Property Organization, as some countries are still calling for a diplomatic conference to finish the treaty, while others are saying agreement on core issues such as what and who the treaty should protect seems elusive. And the committee discussion of copyright exceptions and limitations was nourished by non-governmental entities explaining the need for those exceptions.

As Patients Wait, WHO Members Chip Away At Decision On Medical R&D Funding

A number of World Health Organization member states attended a meeting last week aimed finding ways to sustainably finance research and development for medical products, especially those for poor populations lacking means to pay high prices. According to the outcome document and a WHO official, they heard many viewpoints from experts and made progress but much was left for the World Health Assembly later this month.

MSF Issues In-Depth Report On R&D And Drug Prices

Médecins Sans Frontières (MSF, Doctor Without Borders) today announced a report detailing what it calls failings in the current system for developing new drugs in ways that all patients can afford and access, and providing proposed policy options for addressing the problems.